The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
CELL CYCLE REGULATION AND APOPTOSIS
Abstract
▪ Abstract Tissue homeostasis requires a balance between cell proliferation and death. Apoptosis and proliferation are linked by cell cycle regulators, and apoptotic stimuli affect both cell proliferation and death. Glucocorticoids induce G1 arrest and apoptosis in transformed lymphoid cells. Decreased expression of the cell cycle components c-myc and cyclin D3 is essential for glucocorticoid-induced growth arrest and death in dividing cells. Other G1 regulators, such as p53, pRb, and E2F, have also been implicated in apoptosis. Mice lacking either p53 or E2F display aberrant cell proliferation and tumor formation, suggesting that these proteins are involved in the elimination of abnormal cells through apoptosis. In contrast, pRb induces G1 arrest and suppresses apoptosis in cultured cells. Mice that lack pRb are nonviable and show ectopic mitosis and massive cell death, suggesting that pRb is an apoptotic suppressor. Further analysis of common components of apoptotic and cell cycle machinery may provide insight into the coordinated regulation of these antagonistic processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Bcl-2 and the regulation of programmed cell death
Reed, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.1.1 · Cited by 2,305
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.
Miyashita, T., Krajewski, S., Krajewska, M., Wang, H., Lin, H., Liebermann, D. A., Hoffman‐Liebermann, B., & Reed, J. C. (1994) · PubMed · Cited by 2,143
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
Hunter, T., & Pines, J. (1994) · Cell · doi:10.1016/0092-8674(94)90543-6 · Cited by 2,091
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., & Kastan, M. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7491 · Cited by 1,837
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
p53 Status and the Efficacy of Cancer Therapy in Vivo
Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., & Jacks, T. (1994) · Science · doi:10.1126/science.7973635 · Cited by 1,469
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C.-C., Herrup, K., Lee, W.-H., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,265
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., & Korsmeyer, S. J. (1989) · Cell · doi:10.1016/0092-8674(89)90174-8 · Cited by 1,213
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
Strasser, A., Harris, A. W., & Cory, S. (1991) · Cell · doi:10.1016/0092-8674(91)90362-3 · Cited by 1,054
Apoptosis: The Biochemistry and Molecular Biology of Programmed Cell Death*
SCHWARTZMAN, R. A., & CIDLOWSKI, J. A. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-2-133 · Cited by 1,040
Self-citationRequirement for a functional Rb-1 gene in murine development
Clarke, A. R., Maandag, E. R., van Roon, M., van der Lugt, N. M. T., van der Valk, M., Hooper, M. L., Berns, A., & te Rielef, H. (1992) · Nature · doi:10.1038/359328a0 · Cited by 1,008
Expression of transcription factor E2F1 induces quiescent cells to enter S phase
Johnson, D. G., Schwarz, J. K., Cress, W. D., & Nevins, J. R. (1993) · Nature · doi:10.1038/365349a0 · Cited by 943
p53-Dependent apoptosis suppresses tumor growth and progression in vivo
Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., & Van Dyke, T. (1994) · Cell · doi:10.1016/0092-8674(94)90534-7 · Cited by 880
Askew, D. S., Ashmun, R. A., Simmons, B. C., & Cleveland, J. L. (1991) · PubMed · Cited by 867
McDonnell, T. J., & Korsmeyer, S. J. (1991) · Nature · doi:10.1038/349254a0 · Cited by 858
p53 and E2F-1 cooperate to mediate apoptosis.
Wu, X., & Levine, A. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3602 · Cited by 839
Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.
Qin, X. Q., Livingston, D. M., Kaelin, W. G., & Adams, P. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10918 · Cited by 756
E2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation
Field, S. J., Tsai, F.-Y., Kuo, F., Zubiaga, A. M., Kaelin, W. G., Livingston, D. M., Orkin, S. H., & Greenberg, M. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81255-6 · Cited by 754
Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression
Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W.-W., Kruzel, E., et al. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3032 · Cited by 734
Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.
Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., et al. (1996) · Nature Medicine · doi:10.1038/nm0996-985 · Cited by 703
Tumor Induction and Tissue Atrophy in Mice Lacking E2F-1
Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., & Dyson, N. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81254-4 · Cited by 698
Cdc25 cell-cycle phosphatase as a target of c-myc
Galaktionov, K., Chen, X., & Beach, D. (1996) · Nature · doi:10.1038/382511a0 · Cited by 690
A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1
Heikkila, R., Schwab, G., Wickstrom, E., Loke, S. L., Pluznik, D. H., Watt, R., & Neckers, L. M. (1987) · Nature · doi:10.1038/328445a0 · Cited by 683
p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
Morgenbesser, S. D., Williams, B. O., Jacks, T., & DePinho, R. A. (1994) · Nature · doi:10.1038/371072a0 · Cited by 610
The MYC protein activates transcription of the alpha-prothymosin gene.
Eilers, M., Schirm, S., & Bishop, J. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07929.x · Cited by 578
Oncogenic activity of the c-Myc protein requires dimerization with Max
Amati, B., Brooks, M. W., Levy, N., Littlewood, T. D., Evan, G. I., & Land, H. (1993) · Cell · doi:10.1016/0092-8674(93)90663-b · Cited by 560
Wagner, A. J., Kokontis, J. M., & Hay, N. (1994) · Genes & Development · doi:10.1101/gad.8.23.2817 · Cited by 539
Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis.
Shan, B., & Lee, W. H. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8166 · Cited by 530
MURRAY, A. W. (1989) · American Zoologist · doi:10.1093/icb/29.2.511 · Cited by 458
Meikrantz, W., & Schlegel, R. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240580205 · Cited by 421
Pan, H., & Griep, A. E. (1994) · Genes & Development · doi:10.1101/gad.8.11.1285 · Cited by 404
Cdk inhibitors in development and cancer
Wade Harper, J., & Elledge, S. J. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)90011-8 · Cited by 399
The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max.
Amati, B., Littlewood, T. D., Evan, G. I., & Land, H. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06202.x · Cited by 385
Cooperative tumorigenic effects of germline mutations in Rb and p53
Williams, B. O., Remington, L., Albert, D. M., Mukai, S., Bronson, R. T., & Jacks, T. (1994) · Nature Genetics · doi:10.1038/ng0894-480 · Cited by 368
The role of c-myc in cell growth
Evan, G. I., & Littlewood, T. D. (1993) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80339-9 · Cited by 365
Golstein, P. (1997) · Science · doi:10.1126/science.275.5303.1081 · Cited by 347
p53-mediated cell death: relationship to cell cycle control.
Yonish-Rouach, E., Grunwald, D., Wilder, S., Kimchi, A., May, E., Lawrence, J. J., May, P., & Oren, M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.3.1415 · Cited by 344
Macleod, K. F., Hu, Y., & Jacks, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01006.x · Cited by 321
Howes, K. A., Ransom, N., Papermaster, D. S., Lasudry, J. G., Albert, D. M., & Windle, J. J. (1994) · Genes & Development · doi:10.1101/gad.8.11.1300 · Cited by 303
Zacksenhaus, E., Jiang, Z., Chung, D., Marth, J. D., Phillips, R. A., & Gallie, B. L. (1996) · Genes & Development · doi:10.1101/gad.10.23.3051 · Cited by 302
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.
Rowan, S., Ludwig, R. L., Haupt, Y., Bates, S., Lu, X., Oren, M., & Vousden, K. H. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00418.x · Cited by 301
Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein
Dyson, N., Bernards, R., Friend, S. H., Gooding, L. R., Hassell, J. A., Major, E. O., Pipas, J. M., Vandyke, T., & Harlow, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.3.1353-1356.1990 · Cited by 290
Murray, A. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90059-0 · Cited by 282
Inhibition of apoptosis by the retinoblastoma gene product.
Haas-Kogan, D. A., Kogan, S. C., Levi, D., Dazin, P., T'Ang, A., Fung, Y. K., & Israel, M. A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07022.x · Cited by 281
Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis.
Jänicke, R. U., Walker, P. A., Lin, X. Y., & Porter, A. G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01089.x · Cited by 247
Attardi, L. D., Lowe, S. W., Brugarolas, J., & Jacks, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00739.x · Cited by 238
E2F and Cell Proliferation: A World Turned Upside Down
Weinberg, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81244-1 · Cited by 233
Essential role for p53-mediated transcription in E1A-induced apoptosis.
Sabbatini, P., Lin, J., Levine, A. J., & White, E. (1995) · Genes & Development · doi:10.1101/gad.9.17.2184 · Cited by 215
COMPTON, M. M., & CIDLOWSKI, J. A. (1986) · Endocrinology · doi:10.1210/endo-118-1-38 · Cited by 212
Self-citationOverexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation.
Singh, P., Wong, S. H., & Hong, W. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06635.x · Cited by 208
p53: the ultimate tumor suppressor gene?
Oren, M. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.13.1397838 · Cited by 206
An, B., & Dou, Q. P. (1996) · PubMed · Cited by 205
DP and E2F proteins: coordinating transcription with cell cycle progression
W.-F. Lam, E., & La Thangue, N. B. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90057-4 · Cited by 204
Multiple members of the E2F transcription factor family are the products of oncogenes.
Xu, G., Livingston, D. M., & Krek, W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1357 · Cited by 194
Myc oncogenes: the enigmatic family
RYAN, K. M., & BIRNIE, G. D. (1996) · Biochemical Journal · doi:10.1042/bj3140713 · Cited by 175
Wyllie, A., Rose, K., Morris, R., Steel, C., Foster, E., & Spandidos, D. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.186 · Cited by 173
p53: a Glimpse at the Puppet Behind the Shadow Play
Friend, S. H. (1994) · Science · doi:10.1126/science.8023155 · Cited by 152
p53-mediated apoptosis in HeLa cells can be overcome by excess pRB.
Haupt, Y., Rowan, S., & Oren, M. (1995) · PubMed · Cited by 133
Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis.
Thulasi, R., Harbour, D. V., & Thompson, E. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46845-1 · Cited by 122
Shan, B., Durfee, T. J., & Lee, W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.679 · Cited by 121
The biochemistry and molecular biology of glucocorticoid-induced apoptosis in the immune system.
Cidlowski, J. A., Kl, K., Evans-Storms, R. B., Montague, J. W., Bortner, C. D., & Hughes, F. M. (1996) · PubMed · Cited by 116
Self-citationFan, G., Ma, X., Kren, B. J., & Steer, C. J. (1996) · PubMed · Cited by 104
Yuh, Y. S., & Thompson, E. B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81706-9 · Cited by 97
Direct involvement of p53 in programmed cell death of oligodendrocytes.
Eizenberg, O., Faber‐Elman, A., Gottlieb, E., Oren, M., Rotter, V., & Schwartz, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07097.x · Cited by 87
p53 and Rb: their cellular roles
Picksley, S. M., & Lane, D. P. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90056-6 · Cited by 84
Glucocorticoid inhibition of c-myc, c-myb, and c-Ki-ras expression in a mouse lymphoma cell line.
Eastman‐Reks, S. B., & Vedeckis, W. V. (1986) · PubMed · Cited by 82
Wang, H., Grand, R. J. A., Milner, A. E., Armitage, R. J., Gordon, J., & Gregory, C. D. (1996) · PubMed · Cited by 70
Rhee, K., Bresnahan, W. A., Hirai, A. M., Hirai, M., & Thompson, E. A. (1995) · PubMed · Cited by 69
Glucocorticoid Regulation of Transcription of the c-mycCellular Protooncogene in P1798 Cells
Forsthoefel, A. M., & Thompson, E. A. (1987) · Molecular Endocrinology · doi:10.1210/mend-1-12-899 · Cited by 68
CDKs and cyclins in transition(s)
Fisher, R. P. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80106-2 · Cited by 66
Glucocorticoid regulation of cyclin D3 gene transcription and mRNA stability in lymphoid cells
Reisman, D., & Thompson, E. A. (1995) · Molecular Endocrinology · doi:10.1210/me.9.11.1500 · Cited by 54
Why are there so many CDK inhibitors?
Xiong, Y. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00012-1 · Cited by 46
Thompson, E. B., Thulasi, R., SAEED, M. F., & Johnson, B. H. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb31383.x · Cited by 25
Cancer Genetics: Is p53 the only real tumor suppressor gene?
Berns, A. J. M. (1994) · Current Biology · doi:10.1016/s0960-9822(94)00031-x · Cited by 18
Glucocorticoid regulation of c-myc promoter utilization in P1798 T-lymphoma cells.
Ma, T., Mahajan, P. B., & Thompson, E. A. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.6.1495494 · Cited by 16
Thompson, E. A. (1991) · PubMed · Cited by 15
Rhee, K., Ma, T., & Thompson, E. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32516-4 · Cited by 12
Cited by
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
Apoptosis and Molecular Targeting Therapy in Cancer
Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y., & Sakuragi, N. (2014) · BioMed Research International · doi:10.1155/2014/150845 · Cited by 1,121
RetractedNeuroendocrine Regulation of Immunity
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957
Apoptosis and apoptotic body: disease message and therapeutic target potentials
Xu, X., Lai, Y., & Hua, Z.-C. (2019) · Bioscience Reports · doi:10.1042/bsr20180992 · Cited by 909
Encinas, M., Iglesias, M., Liu, Y., Wang, H., Muhaisen, A., Ceña, V., Gallego, C., & Comella, J. X. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750991.x · Cited by 820
Metadata
- Authors
- King, K. L., & Cidlowski, J. A.
- Venue
- Annual Review of Physiology
- Publisher
- Annual Reviews
- Published
- 1998-10
- Volume
- 60
- Issue
- 1
- Pages
- 601-617
- ISSN
- 0066-4278 (ISSN-L)
- 1545-1585
- OpenAlex
- W2143938651
- Cited by
- 531
- References
- 90
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.